stoxline Quote Chart Rank Option Currency Glossary
ProKidney Corp. (PROK)
1.82  0.14 (8.33%)    12-06 16:00
Open: 1.68
High: 1.9299
Volume: 665,308
Pre. Close: 1.68
Low: 1.615
Market Cap: 122(M)
Technical analysis
2023-12-06 4:23:37 PM
Short term     
Mid term     
Targets 6-month :  2.52 1-year :  2.95
Resists First :  2.16 Second :  2.52
Pivot price 1.65
Supports First :  1.51 Second :  1.12
MAs MA(5) :  1.67 MA(20) :  1.64
MA(100) :  5.95 MA(250) :  8.63
MACD MACD :  -0.2 Signal :  -0.3
%K %D K(14,3) :  52.9 D(3) :  50
RSI RSI(14): 47
52-week High :  14.18 Low :  1.12
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PROK ] has closed below upper band by 30.4%. Bollinger Bands are 69.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.93 - 1.94 1.94 - 1.95
Low: 1.6 - 1.61 1.61 - 1.61
Close: 1.81 - 1.82 1.82 - 1.83
Company Description

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Headline News

Fri, 01 Dec 2023
ProKidney: Getting Easier To Comprehend Now (NASDAQ:PROK) - Seeking Alpha

Thu, 30 Nov 2023
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer - ProKidney (NASDAQ:PROK) - Benzinga

Fri, 17 Nov 2023
Here's Why We're Not Too Worried About ProKidney's (NASDAQ:PROK) Cash Burn Situation - Simply Wall St

Fri, 17 Nov 2023
ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript - Yahoo Finance

Thu, 16 Nov 2023
After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK) - Yahoo Finance

Tue, 14 Nov 2023
ProKidney Reports Third Quarter Financial Results - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 67 (M)
Shares Float 49 (M)
Held by Insiders 22.3 (%)
Held by Institutions 65.3 (%)
Shares Short 10,500 (K)
Shares Short P.Month 8,770 (K)
Stock Financials
EPS -0.58
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -17.74
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -20.1 %
Return on Equity (ttm) -29.2 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -2.3
Qtrly Earnings Growth 0 %
Operating Cash Flow -80 (M)
Levered Free Cash Flow -68 (M)
Stock Valuations
PE Ratio -3.14
PEG Ratio 0
Price to Book value -0.11
Price to Sales 0
Price to Cash Flow -1.52
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android